Luxembourg-based investment group CIP has placed a 10% stake in Tate & Lyle on the market, not long after the UK-based sugar and sweetener group was readmitted to the FTSE 100 index of leading shares.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Tate & Lyle’s stock was readmitted to the FTSE 100 index, after a seven year absence, on the back of the recent strong performance by the shares, reported the Financial Times.
CIP’s sale of the stake ends a near 30-year relationship between the two companies that began when Tate bought a stake in Amylum, CIP’s European starch business, in 1976. Tate bought CIP’s stake in Amylum and also its US starch business Staley for £274m (US$521.5m) in 2000.